Page 3 - சீர்குலைக்கும் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Source: Freudenberg Medical Carrick-on-Shannon, Ireland  ̶  VistaMed, a Freudenberg Medical company and leading CDMO for complex extrusions, finished catheters, and medical devices for minimally invasive applications, is pleased to announce that they are part of a team that has been awarded €5.1 million over a three-year period for a project that aims to provide the first catheter to deliver direct 3D, intraprocedural analysis of the success of cardiac ablation, in the treatment of atrial fibrillation. Atrial fibrillation or AFib is an irregular heartbeat or cardiac arrhythmia which can lead to blood clots, stroke, and heart failure. First procedure success rates for patients with atrial fibrillation undergoing cardiac ablation can be as low as 50% and OneProjects aims to increase this significantly. The innovative product ‘VERAFEYE’ will be able to provide 4D cardiac imaging for navigation and therapy planning as well as confirm to clinicians where the lesions are being

Carrick on shannonPatrick mulhollandTyndall national instituteDisruptive technology innovation fundIreland vistamedFreudenberg medicalDisruptive technologyInnovation fundManaging directorகேரிக் ஆன் ஶ்யாநந்பேட்ரிக் மல்ஹால்யாஂட்டைண்டால் தேசிய நிறுவனம்சீர்குலைக்கும் தொழில்நுட்பம் கண்டுபிடிப்பு நிதிஃப்ரூடன்பெர்க் மருத்துவசீர்குலைக்கும் தொழில்நுட்பம்கண்டுபிடிப்பு நிதி